Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Grows By 199.4%

Applied DNA Sciences, Inc. (NASDAQ:APDN) was the recipient of a significant growth in short interest in December. As of December 15th, there was short interest totalling 5,300,000 shares, a growth of 199.4% from the November 30th total of 1,770,000 shares. Based on an average daily volume of 5,810,000 shares, the short-interest ratio is presently 0.9 days.

Analysts Set New Price Targets

Separately, StockNews.com raised Applied DNA Sciences to a “sell” rating in a research note on Tuesday, September 17th.

Applied DNA Sciences Trading Up 0.7 %

Shares of Applied DNA Sciences stock traded up $0.00 during mid-day trading on Friday, reaching $0.18. 3,452,442 shares of the stock were exchanged, compared to its average volume of 4,233,988. The company has a market cap of $9.41 million, a price-to-earnings ratio of -0.02 and a beta of 0.46. Applied DNA Sciences has a fifty-two week low of $0.12 and a fifty-two week high of $14.40. The firm has a 50-day simple moving average of $0.20 and a 200 day simple moving average of $0.58.

Applied DNA Sciences (NASDAQ:APDN) last posted its earnings results on Tuesday, December 17th. The technology company reported ($0.32) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.01. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%. On average, research analysts predict that Applied DNA Sciences will post -1.8 EPS for the current fiscal year.

Hedge Funds Weigh In On Applied DNA Sciences

An institutional investor recently bought a new position in Applied DNA Sciences stock. Jane Street Group LLC acquired a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 73,396 shares of the technology company’s stock, valued at approximately $48,000. Jane Street Group LLC owned about 0.24% of Applied DNA Sciences at the end of the most recent reporting period. 22.22% of the stock is currently owned by institutional investors.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.